216 related articles for article (PubMed ID: 28406729)
1. Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.
Kendig RD; Kai F; Fry EA; Inoue K
Cancer Invest; 2017 May; 35(5):301-312. PubMed ID: 28406729
[TBL] [Abstract][Full Text] [Related]
2. The Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1.
Mallakin A; Sugiyama T; Kai F; Taneja P; Kendig RD; Frazier DP; Maglic D; Matise LA; Willingham MC; Inoue K
Int J Cancer; 2010 Mar; 126(6):1403-16. PubMed ID: 19816943
[TBL] [Abstract][Full Text] [Related]
3. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
[TBL] [Abstract][Full Text] [Related]
4. Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function.
Frazier DP; Kendig RD; Kai F; Maglic D; Sugiyama T; Morgan RL; Fry EA; Lagedrost SJ; Sui G; Inoue K
Cancer Res; 2012 Apr; 72(7):1740-50. PubMed ID: 22331460
[TBL] [Abstract][Full Text] [Related]
5. Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
Mallakin A; Sugiyama T; Taneja P; Matise LA; Frazier DP; Choudhary M; Hawkins GA; D'Agostino RB; Willingham MC; Inoue K
Cancer Cell; 2007 Oct; 12(4):381-94. PubMed ID: 17936562
[TBL] [Abstract][Full Text] [Related]
6. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
[TBL] [Abstract][Full Text] [Related]
8. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
[TBL] [Abstract][Full Text] [Related]
9. Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.
Tschan MP; Federzoni EA; Haimovici A; Britschgi C; Moser BA; Jin J; Reddy VA; Sheeter DA; Fischer KM; Sun P; Torbett BE
Biochim Biophys Acta; 2015 Sep; 1849(9):1198-208. PubMed ID: 26187004
[TBL] [Abstract][Full Text] [Related]
10. DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death.
Hill R; Madureira PA; Waisman DM; Lee PW
Oncotarget; 2011 Dec; 2(12):1094-108. PubMed ID: 22190353
[TBL] [Abstract][Full Text] [Related]
11. Dmp1 and tumor suppression.
Inoue K; Mallakin A; Frazier DP
Oncogene; 2007 Jun; 26(30):4329-35. PubMed ID: 17237816
[TBL] [Abstract][Full Text] [Related]
12. p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements.
Quaas M; Müller GA; Engeland K
Cell Cycle; 2012 Dec; 11(24):4661-72. PubMed ID: 23187802
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
14. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
15. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
16. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract][Full Text] [Related]
17. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway.
Li DQ; Pakala SB; Reddy SDN; Ohshiro K; Peng SH; Lian Y; Fu SW; Kumar R
J Biol Chem; 2010 Mar; 285(13):10044-10052. PubMed ID: 20071335
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
19. Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.
Liu PY; Hsieh TY; Liu ST; Chang YL; Lin WS; Wang WM; Huang SM
Exp Cell Res; 2011 Dec; 317(20):2925-37. PubMed ID: 22001409
[TBL] [Abstract][Full Text] [Related]
20. BAF53 interacts with p53 and functions in p53-mediated p21-gene transcription.
Wang M; Gu C; Qi T; Tang W; Wang L; Wang S; Zeng X
J Biochem; 2007 Nov; 142(5):613-20. PubMed ID: 17878219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
